Search Results - "Alexander, Marcus"

Refine Results
  1. 1

    Navigating the new landscape of second‐line treatment in advanced hepatocellular carcinoma by Rimassa, Lorenza, Wörns, MarcusAlexander

    Published in Liver international (01-08-2020)
    “…Sorafenib and lenvatinib are approved for first‐line treatment of patients with advanced hepatocellular carcinoma (HCC), and the efficacy of atezolizumab plus…”
    Get full text
    Journal Article
  2. 2

    HCC therapies—lessons learned by Wörns, Marcus-Alexander, Galle, Peter Robert

    “…Advancing the field of therapeutics for hepatocellular carcinoma has been far more challenging than initially anticipated; sorafenib is the only approved…”
    Get full text
    Journal Article
  3. 3

    Predictors of advanced fibrosis in non‐cirrhotic non‐alcoholic fatty liver disease in Germany by Labenz, Christian, Huber, Yvonne, Kalliga, Eva, Nagel, Michael, Ruckes, Christian, Straub, Beate K., Galle, Peter R., Wörns, MarcusAlexander, Anstee, Quentin M., Schuppan, Detlef, Schattenberg, Jörn M.

    Published in Alimentary pharmacology & therapeutics (01-11-2018)
    “…Summary Background Advanced fibrosis has been established as the most important predictor of overall mortality in patients with non‐alcoholic fatty liver…”
    Get full text
    Journal Article
  4. 4

    Quantitative Particle Uptake by Cells as Analyzed by Different Methods by Ashraf, Sumaira, Hassan Said, Alaa, Hartmann, Raimo, Assmann, MarcusAlexander, Feliu, Neus, Lenz, Peter, Parak, Wolfgang J.

    Published in Angewandte Chemie International Edition (27-03-2020)
    “…There is a large number of two‐dimensional static in vitro studies about the uptake of colloidal nano‐ and microparticles, which has been published in the last…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Hydrogels as Emerging Materials for Cornea Wound Healing by Khosravimelal, Sadjad, Mobaraki, Mohammadmahdi, Eftekhari, Samane, Ahearne, Mark, Seifalian, Alexander Marcus, Gholipourmalekabadi, Mazaher

    “…Hydrogel biomaterials have many favorable characteristics including tuneable mechanical behavior, cytocompatibility, optical properties suitable for…”
    Get full text
    Journal Article
  7. 7

    Letter: diabetes mellitus increases the risk of hepatic encephalopathy in patients with cirrhosis—authors’ reply by Labenz, Christian, Wörns, MarcusAlexander

    Published in Alimentary pharmacology & therapeutics (01-10-2020)
    “…LINKED CONTENT This article is linked to Labenz et al and Liu et al papers. To view these articles, visit https://doi.org/10.1111/apt.15915 and…”
    Get full text
    Journal Article
  8. 8

    Raised serum Interleukin‐6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy by Labenz, Christian, Toenges, Gerrit, Huber, Yvonne, Nagel, Michael, Marquardt, Jens U., Schattenberg, Jörn M., Galle, Peter R., Labenz, Joachim, Wörns, MarcusAlexander

    Published in Alimentary pharmacology & therapeutics (01-11-2019)
    “…Summary Background Systemic inflammation is a driving force for the development of hepatic encephalopathy and recent studies demonstrated that elevated…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Natural polymers in wound healing: From academic studies to commercial products by Tavakoli, Mohamadreza, Labbaf, Sheyda, Mirhaj, Marjan, Salehi, Saeideh, Seifalian, Alexander Marcus, Firuzeh, Mahboubeh

    Published in Journal of applied polymer science (10-06-2023)
    “…Natural biopolymers (carbohydrates and proteins) are the family of natural polymers that are widely used in wound healing. This is due to their…”
    Get full text
    Journal Article
  11. 11

    Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population‐based study by Labenz, Christian, Wörns, MarcusAlexander, Adarkwah, Charles C., Galle, Peter R., Schattenberg, Jörn M., Kostev, Karel

    Published in Alimentary pharmacology & therapeutics (01-09-2020)
    “…Summary Background Bone fractures are a frequent complication in patients with cirrhosis. Proton pump inhibitors (PPIs) are among the most frequently…”
    Get full text
    Journal Article
  12. 12

    Context Modularity of Human Altruism by Alexander, Marcus, Christia, Fotini

    “…Whereas altruism drives the evolution of human cooperation, ethno-religious diversity has been considered to obstruct it, leading to poverty, corruption, and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Immune oncology in hepatocellular carcinoma—hype and hope by Wörns, Marcus-Alexander, Galle, Peter R

    Published in The Lancet (British edition) (24-06-2017)
    “…Thus, the definition of a first and so far only standard of care for hepatocellular carcinoma, a milestone 10 years ago, was followed by gridlock; no standard…”
    Get full text
    Journal Article
  15. 15

    Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis by Labenz, Christian, Nagel, Michael, Kremer, Wolfgang M., Hilscher, Max, Schilling, Caroline A., Toenges, Gerrit, Kuchen, Robert, Schattenberg, Jörn M., Galle, Peter R., Wörns, MarcusAlexander

    Published in Alimentary pharmacology & therapeutics (01-08-2020)
    “…Summary Background Diabetes mellitus may lead to increased serum ammonia and systemic inflammation thereby promoting hepatic encephalopathy (HE). Aim To…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis by Michel, Maurice, Hess, Cornelius, Kaps, Leonard, Kremer, Wolfgang M., Hilscher, Max, Galle, Peter R., Moehler, Markus, Schattenberg, Jörn M., Wörns, Marcus-Alexander, Labenz, Christian, Nagel, Michael

    Published in Scientific reports (15-10-2021)
    “…Methylglyoxal (MGO) is a highly reactive dicarbonyl species that forms advanced glycation end products (AGEs). The binding of these AGEs to their receptor…”
    Get full text
    Journal Article
  18. 18

    Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis by Labenz, Christian, Kostev, Karel, Galle, Peter R., Wörns, Marcus-Alexander, Labenz, Joachim, Tanislav, Christian, Adarkwah, Charles Christian

    Published in Medicine (Baltimore) (11-12-2020)
    “…There is evidence that intake of proton pump inhibitors (PPI) increases the risk for spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis…”
    Get full text
    Journal Article
  19. 19

    Transient binding of dynein controls bidirectional long-range motility of early endosomes by Schuster, Martin, Lipowsky, Reinhard, Assmann, Marcus-Alexander, Lenz, Peter, Steinberg, Gero

    “…In many cell types, bidirectional long-range endosome transport is mediated by the opposing motor proteins dynein and kinesin-3. Here we use a fungal model…”
    Get full text
    Journal Article
  20. 20

    Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection by Labenz, Christian, Kremer, Wolfgang M., Schattenberg, Jörn M., Wörns, Marcus-Alexander, Toenges, Gerrit, Weinmann, Arndt, Galle, Peter R., Sprinzl, Martin F.

    Published in Journal of investigative medicine (01-08-2020)
    “…Predictive factors for adverse outcomes in patients with COVID-19 are urgently needed. Data related to the applicability of the Clinical Frailty Scale (CFS)…”
    Get full text
    Journal Article